Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Taking Propecia might lead to the development of cataracts.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Finasteride, often used for hair loss, can potentially cause cataracts.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

The document explains various skin conditions and their treatments.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Targeting Vδ1+T-cells may help treat alopecia areata.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.